Caladrius Biosciences

Return to Grants

Total Awards:
Award Value:
Institution type:
For profit
Short Name:
Caladrius Biosciences

Awards to the Institution

Program Type Investigator Grant Title Award Value
Clinical Trial Stage Projects Dr. William Sietsema Phase 2 Safety and Efficacy Study of CLBS03 Autologous T-Regulatory Cells in Adolescents with Recent Onset Type 1 Diabetes Mellitus $8,175,946
Clinical Trial Stage Projects Robert Dillman Tumor stem cell-targeted immunotherapy for metastatic melanoma –a randomized phase 3 clinical trial. $3,000,000